Miao Q - Search Results

1

Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody-Drug Conjugate LR-DM1 for Pancreatic Cancer.

Zhu M, Zhou L, Hu S, Miao Q, Gong J, Zhang N, Zhang G, Wang M, Wang J, He H, Wang Y. Zhu M, et al. Among authors: miao q. J Med Chem. 2022 May 26;65(10):7141-7153. doi: 10.1021/acs.jmedchem.1c01920. Epub 2022 May 6. J Med Chem. 2022. PMID: 35522590

2

Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.

Sheng W, Shang Y, Miao Q, Li Y, Zhen Y. Sheng W, et al. Among authors: miao q. Anticancer Drugs. 2012 Apr;23(4):406-16. doi: 10.1097/CAD.0b013e32834f9801. Anticancer Drugs. 2012. PMID: 22205154

3

[An overview of antibody-based cancer therapy].

Miao QF, Shao RG, Zhen YS. Miao QF, et al. Yao Xue Xue Bao. 2012 Oct;47(10):1261-8. Yao Xue Xue Bao. 2012. PMID: 23289136 Review. Chinese.

4

A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30⁺ lymphomas.

Wang R, Li L, Zhang S, Li Y, Wang X, Miao Q, Zhen Y. Wang R, et al. Among authors: miao q. Mol Oncol. 2018 Mar;12(3):339-355. doi: 10.1002/1878-0261.12166. Epub 2018 Jan 26. Mol Oncol. 2018. PMID: 29316337 Free PMC article.

5

An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies.

Hu XY, Wang R, Jin J, Liu XJ, Cui AL, Sun LQ, Li YP, Li Y, Wang YC, Zhen YS, Miao QF, Li ZR. Hu XY, et al. Mol Oncol. 2019 Feb;13(2):246-263. doi: 10.1002/1878-0261.12400. Epub 2018 Nov 15. Mol Oncol. 2019. PMID: 30372581 Free PMC article.

6

Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma.

Wang R, Li L, Duan A, Li Y, Liu X, Miao Q, Gong J, Zhen Y. Wang R, et al. Among authors: miao q. Cancer Lett. 2019 Apr 28;448:84-93. doi: 10.1016/j.canlet.2019.02.002. Epub 2019 Feb 8. Cancer Lett. 2019. PMID: 30742941

7

Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.

Gong JH, Zheng YB, Zhang MR, Wang YX, Yang SQ, Wang RH, Miao QF, Liu XJ, Zhen YS. Gong JH, et al. Cancer Biol Ther. 2020 Apr 2;21(4):332-343. doi: 10.1080/15384047.2019.1702399. Epub 2020 Jan 7. Cancer Biol Ther. 2020. PMID: 31906826 Free PMC article.

8

Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models.

Gong J, Guo F, Cheng W, Fan H, Miao Q, Yang J. Gong J, et al. Among authors: miao q. Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):408-414. doi: 10.1080/21691401.2019.1709857. Artif Cells Nanomed Biotechnol. 2020. PMID: 31913714 Free article.

9

Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates.

Hu X, Jiang H, Bai W, Liu X, Miao Q, Wang L, Jin J, Cui A, Liu R, Li Z. Hu X, et al. Among authors: miao q. Eur J Med Chem. 2021 Apr 15;216:113297. doi: 10.1016/j.ejmech.2021.113297. Epub 2021 Feb 24. Eur J Med Chem. 2021. PMID: 33677351

10

Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.

Zhou DD, Bai WQ, Zhai XT, Sun LP, Zhen YS, Li ZR, Miao QF. Zhou DD, et al. Mil Med Res. 2021 Dec 9;8(1):63. doi: 10.1186/s40779-021-00358-9. Mil Med Res. 2021. PMID: 34879870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,419 results

Search Page

Filters